NAOV_OUT_1 [2025-03-20 12:50:50 -0400] 2048 Bytes | 572 tokens | Cum: 572 tkns (7.15% of 8k)
==========================================================================

We're scouting for winners today. Its 12:50:47 PM on Thursday March 20, 2025 ET (UTC-0400) and I'm looking at NanoVibronix (NAOV) up to 3.882 from 3.26

Help me investigate to see if its got potential or just another dud. So, I pulled together a bunch of data for you to look over real fast.

Here's the first list of news for NanoVibronix:

C1 - Mar-14-25 08:00AM - Successful Independent Study of the NanoVibronix UroShield Device Published in the Australian and New Zealand Continence Journal
C2 - Mar-12-25 08:00AM - NanoVibronix Announces Reverse Stock Split
C3 - Feb-14-25 09:43AM - NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp.
C4 - Jan-07-25 08:00AM - NanoVibronix Advances Development of PainShield and UroShield with Completion of NextGen Prototypes
C5 - Jan-07-25 08:00AM 05:53AM - Transforming catheter care: NanoVibronix completes successful UroShield US trial
C6 - Jan-06-25 11:16AM - NanoVibronix achieves goals of US trial pilot phase with UroShield
C7 - Jan-06-25 11:16AM 08:00AM - NanoVibronix Announces Completion of Pilot Phase of Clinical Study of UroShield at the University of Michigan
C8 - Dec-11-24 08:00AM - NanoVibronix Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution Agreement

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on NanoVibronix (NAOV)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

NAOV_OUT_3 [2025-03-20 12:50:54 -0400] 505 Bytes | 140 tokens | Cum: 714 tkns (8.92% of 8k)
==========================================================================

Showing C1 (chunk 1 of 1): C1:
**Successful Independent Study of the NanoVibronix UroShield Device Published in the Australian and New Zealand Continence Journal**
Date: Mar-14-25 08:00AM
Source: (Business Wire)
URL: https://www.businesswire.com/news/home/20250314149883/en

Error fetching article: 403 Client Error: Forbidden for url: https://www.businesswire.com/news/home/20250314149883/en

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

NAOV_OUT_5 [2025-03-20 12:50:56 -0400] 987 Bytes | 294 tokens | Cum: 1104 tkns (13.80% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-17T14:35:38Z - NanoVibronix (NAOV) Stock Is Skyrocketing: What's Going On? - NanoVibronix (NASDAQ:NAOV)...
A2 - 2025-03-17T11:40:57Z - Why Precision BioSciences Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket...
A3 - 2025-03-14T20:35:05Z - U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.65% By Investing.com...
A4 - 2025-03-14T20:36:19Z - United States shares higher at close of trade; Dow Jones Industrial Average up 1.65% By Investing.co...
A5 - 2025-03-14T12:10:31Z - NanoVibronix announces UroShield health service study data published...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

NAOV_OUT_7 [2025-03-20 12:50:57 -0400] 1038 Bytes | 296 tokens | Cum: 1402 tkns (17.52% of 8k)
==========================================================================

Showing A1 (chunk 1 of 4): A1:
**NanoVibronix (NAOV) Stock Is Skyrocketing: What's Going On? - NanoVibronix (NASDAQ:NAOV)**Date: 2025-03-17Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/news/25/03/44357757/nanovibronix-naov-stock-is-skyrocketing-whats-going-onJoin Nic Chahine live on Wednesday, March 19, at 6 PM ET for a step-by-step breakdown of how to to capitalize on post-Fed volatility and manage risk in this fast-moving market. Register for this free strategy session today.

NanoVibronix Inc NAOV shares are trading higher by 37.4% to $3.03 during Monday's session after the company announced Friday that it published its UroShield study, which showed positive data, including an 86% UTI reduction.

What To Know: NanoVibronix announced that a study on its UroShield device, published in The Australian and New Zealand Continence Journal, confirms its effectiven

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

NAOV_OUT_9 [2025-03-20 12:50:59 -0400] 882 Bytes | 281 tokens | Cum: 1685 tkns (21.06% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2023-11-07T14:26:29Z - Penny Stocks To Buy Now? 3 to Watch With Big News
B2 - 2023-10-16T17:09:53Z - Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
B3 - 2023-08-31T10:24:00Z - What Makes a Successful Penny Stocks Trader?
B4 - 2023-08-30T17:17:51Z - Why REX American Resources Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
B5 - 2023-08-30T16:28:04Z - Gold Moves Higher; Outlook Therapeutics Shares Plummet
B6 - 2023-08-30T14:04:02Z - Dow Surges 150 Points; US Economy Grows At 2.1% Pace In Q2

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

NAOV_OUT_11 [2025-03-20 12:51:02 -0400] 520 Bytes | 148 tokens | Cum: 1835 tkns (22.94% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**Penny Stocks To Buy Now? 3 to Watch With Big News**Date: Unknown DateSource: Unknown SourceURL: https://pennystocks.com/featured/2023/11/07/penny-stocks-to-buy-now-3-to-watch-with-big-news/Biotech penny stocks to watch this week.
The post Penny Stocks To Buy Now? 3 to Watch With Big News appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

NAOV_OUT_13 [2025-03-20 12:51:03 -0400] 1168 Bytes | 318 tokens | Cum: 2190 tkns (27.38% of 8k)
==========================================================================

This is our list of SEC filings.
Read it just by asking.
Don't miss breaking filings!

S1 - 2025-03-14 8-K Item 7.01 Regulation FD Disclosure.

On March 14, 2025, NanoVibronix, Inc. (the Company ) issued a press release announcing an independent health service study of its UroShield is published in The Australian and New Zealand Continence Journal . A copy of the press release is fur...

S2 - 2025-03-14 8-K Item 7.01 Regulation FD Disclosure.

On March 14, 2025, NanoVibronix, Inc. (the Company ) issued a press release announcing an independent health service study of its UroShield is published in The Australian and New Zealand Continence Journal . A copy of the press release is fur...

S3 - 2025-02-14 8-K Item 1.01. Entry into a Material Definitive Agrmt.

Merger with ENvue Medical Holdings, Corp.

Agrmt and Plan of Merger

On February 14, 2025, Nanovibronix, Inc., a Delaware corporation (the Company ) entered into that certain Agrmt and Plan of Merger (the Merger A...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing - but what fun is that?
Response limited to 3 chars.

NAOV_OUT_15 [2025-03-20 12:51:05 -0400] 1038 Bytes | 252 tokens | Cum: 2444 tkns (30.55% of 8k)
==========================================================================

Showing S1 (chunk 1 of 2): S1:
Item 7.01 Regulation FD Disclosure.

On March 14, 2025, NanoVibronix, Inc. (the Company ) issued a press release announcing an independent health service study of its UroShield is published in The Australian and New Zealand Continence Journal . A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.

The information in this Current Report on Form 8-K (including Exhibit 99.1 attached hereto) is being furnished pursuant to Item 7.01 and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act ), or otherwise be subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date here

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

NAOV_OUT_17 [2025-03-20 12:51:19 -0400] 4851 Bytes | 1431 tokens | Cum: 3877 tkns (48.46% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+-------------------+-----------------------+---------------------+------------------------+-----------------------+-------------------+
| Volume: 267,038 | SMA50: -12.81% | Market Cap: 3.12M | Option/Short: No / Yes | Sales past 5Y: 84.39% | Sales Surprise: - |
+-------------------+-----------------------+---------------------+------------------------+-----------------------+-------------------+
| Avg Volume: 1.07M | SMA200: -39.74% | Shs Outstand: 0.79M | Short Float: 0.28% | Employees: 16 | EPS Surprise: - |
+-------------------+-----------------------+---------------------+------------------------+-----------------------+-------------------+
| Rel Volume: 0.50 | Perf Week: 49.17% | Shs Float: 0.79M | Short Ratio: 0.00 | Debt/Eq: 0.07 | P/E: - |
+-------------------+-----------------------+---------------------+------------------------+-----------------------+-------------------+
| RSI (14): 51.12 | Perf Month: -9.40% | Inst Own: 4.17% | Short Interest: 0.00M | Sales Y/Y TTM: - | Earnings: - |
+-------------------+-----------------------+---------------------+------------------------+-----------------------+-------------------+
| ATR (14): 0.72 | Perf Quarter: -41.24% | Insider Own: 0.00% | Beta: 1.87 | ROE: -94.09% | |
+-------------------+-----------------------+---------------------+------------------------+-----------------------+-------------------+
| SMA20: 11.57% | Index: - | Insider Trans: - | Sales Q/Q: -17.90% | ROI: -158.39% | |
+-------------------+-----------------------+---------------------+------------------------+-----------------------+-------------------+

The next section covers any insider trading.
If this section is blank, it's because there've been no recent filings.

Inside Trans: NanoVibronix, Inc. (NAOV) by Murphy Brian M (Chief Executive Officer) on 2024-12-30
- Option to Purchase Common Stock: 80000 shares at $0 (D)

Inside Trans: NanoVibronix, Inc. (NAOV) by Cassirer Aurora (Unknown Title) on 2024-12-30
- Option to Purchase Common Stock: 20000 shares at $0 (D)

Inside Trans: NanoVibronix, Inc. (NAOV) by FASHEK CHRISTOPHER M (Unknown Title) on 2024-12-30
- Option to Purchase Common Stock: 50000 shares at $0 (D)

Inside Trans: NanoVibronix, Inc. (NAOV) by JACOB HAROLD (Chief Medical Officer) on 2024-12-30
- Option to Purchase Common Stock: 10000 shares at $0 (D)

[Company Financial Summary]
[Company Details]
Name: NanoVibronix, Inc. Common Stock
Market Cap: N/A
Shares Outstanding: N/A
Sector: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 376000, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -998000, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 4
Average Volume: 1945281.35
30-Day High: 4.6123
30-Day Low: 2.2059

[Detailed Financials: Q3 2024]
- Total Assets: $4,682,000.0
- Total Liabilities: $2,810,000.0
- Total Equity: $1,872,000.0
- Current Assets: $4,377,000.0
- Current Liabilities: $2,521,000.0

[Income Statement: Q3 2024]
- Revenue: $376,000
- Net Income: $-998,000
- Operating Income: $-970,000
- Earnings Per Share (EPS): -0.36

[Cash Flow Statement: Q3 2024]
- Net Cash Flow: $-863,000

[Detailed Financials: Q2 2024]
- Total Assets: $5,696,000.0
- Total Liabilities: $2,855,000.0
- Total Equity: $2,841,000.0
- Current Assets: $5,386,000.0
- Current Liabilities: $2,556,000.0

[Income Statement: Q2 2024]
- Revenue: $817,000
- Net Income: $-688,000
- Operating Income: $-674,000
- Earnings Per Share (EPS): -0.25

[Cash Flow Statement: Q2 2024]
- Net Cash Flow: $-1,107,000.0
==== END OF FINANCIAL REPORT ====

Now we've reached the end of the analysis.
You are now requested to make a summary analysis.
Please don't explain why you didn't have enough information.
Save that for the survey that comes last.

Finish the summary with two scores: MARKET_SCORE[] and PRICE_TARGET[]

If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
If you think the high today will be 50% higher, add to the price. Eg., If the price is $5.00, add 50%: PRICE_TARGET[$7.50]
PRICE_TARGET is the highest it is expected to rise today, so it cannot be less than the current price.
Please provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-10 words headline for news story from first summary paragraph]
1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

NAOV_OUT_19 [2025-03-20 12:51:21 -0400] 561 Bytes | 131 tokens | Cum: 4302 tkns (53.77% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings & insider data
-> X3 <- Broader sector & market news
-> X4 <- General market sentiment & AI confidence levels
-> X5 <- AI's past analysis on similar companies
-> X6 <- More financial metrics
-> X7 <- AI's past analysis on this exact company
-> X8 <- Something altogether different (explain...)

NAOV_IN_21 [2025-03-20 12:51:22 -0400] 126 Bytes | 29 tokens | Cum: 4341 tkns (54.26% of 8k)
==========================================================================

====================================
[2025-03-20 09:51:22] # Analysis Completed
Elapsed Time: 34.90 seconds